JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 20, 2006; DOI: 10.1124/jpet.106.104620


0022-3565/06/3193-1104-1111$20.00
JPET 319:1104-1111, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104620v1
319/3/1104    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serna, H.
Right arrow Articles by Vergara, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serna, H.
Right arrow Articles by Vergara, P.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Mast Cell Stabilizer Ketotifen [4-(1-Methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one Fumarate] Prevents Mucosal Mast Cell Hyperplasia and Intestinal Dysmotility in Experimental Trichinella spiralis Inflammation in the Rat

H. Serna, M. Porras, and P. Vergara

Department of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Spain

Trichinella spiralis infection in rats induces hypermotility and an abnormal response to cholecystokinin (CCK) similar to motor disturbances observed in irritable bowel syndrome. Mast cell hyperplasia is also characteristic of this experimental model. The aim of our study was to correlate mast cell activity with the development of dysmotility and to demonstrate whether the mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] could prevent the development of intestine hypermotility. Sprague-Dawley rats were infected with T. spiralis and, 5 days after infection, treated with the mast-cell stabilizer ketotifen (10 mg/kg/day). Twelve days after infection, intestinal spontaneous motor activity and response to CCK were evaluated by means of strain-gauge transducers. Immunohistochemistry for rat mast cell protease II (RMCPII), cyclooxygenase (COX)-2, and inducible nitric-oxide synthase (iNOS) was performed in intestinal specimens. In addition, RMCPII and myeloperoxidase were determined in serum. Infected control rats showed hypermotility, mast cell hyperplasia, increased RMCPII levels, increased myeloperoxidase, and overexpression of COX-2 and iNOS. In contrast, ketotifen-treated rats showed spontaneous intestinal motility and CCK response similar to the noninfected control rats. Mast cell hyperplasia and RMCPII were reduced in ketotifen-treated rats. Inflammatory parameters were less modified by ketotifen, but those animals that received the longest ketotifen treatment showed a slight amelioration in these parameters. These results indicate that mast cells are implicated in the development of hypermotility. The treatment with ketotifen prevented hypermotility and mast cell hyperplasia and diminished mucosal mast cell activity.


Received for publication March 15, 2006
Accepted September 18, 2006.

Address correspondence to: Dr. Patri Vergara, Unidad de Fisiologia, Facultad de Veterinaria, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain. E-mail: patri.vergara{at}uab.es




This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. Khaldi, G. Gargala, L. Le Goff, S. Parey, A. Francois, J. Fioramonti, J.-J. Ballet, J.-P. Dupont, P. Ducrotte, and L. Favennec
Cryptosporidium parvum Isolate-Dependent Postinfectious Jejunal Hypersensitivity and Mast Cell Accumulation in an Immunocompetent Rat Model
Infect. Immun., November 1, 2009; 77(11): 5163 - 5169.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Li, A. Zhao, T. Shea-Donohue, and S. M. Singer
Mast Cell-Mediated Changes in Smooth Muscle Contractility during Mouse Giardiasis
Infect. Immun., September 1, 2007; 75(9): 4514 - 4518.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R. Roka, A. Ait-Belgnaoui, C. Salvador-Cartier, R. Garcia-Villar, J. Fioramonti, H. Eutamene, and L. Bueno
Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats
Gut, August 1, 2007; 56(8): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
C. B. Collins, J. McGrath, A. W. Baird, and D. P. Campion
Effect of Mast Cell Degranulation on Chicken Ileal Ion Transport In Vitro
Poult. Sci., May 1, 2007; 86(5): 843 - 849.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.